To Investigate the Associations of Dyslipidemia and BMI, as Risk Factors Leading to Insulin Resistance and Development of Type2 Diabetes Mellitus in Baqubah City

Safa Nadhum Mohammed; Walaa Esmael Jassim; Najah Ali Mohammed

doi:10.51173/jt.v4i3.538

Authors

Safa Nadhum Mohammed Diyala Health Department - Public Health Department - Public Health Laboratory
Walaa Esmael Jassim College of Health & Medical Technology - Baghdad, Middle Technical University, Baghdad, Iraq
Najah Ali Mohammed Institute of Medical Technology / Baghdad, Middle Technical University, Baghdad, Iraq

DOI:

https://doi.org/10.51173/jt.v4i3.538

Keywords:

Insulin resistance, HOMAIR, Lipid profile, BMI, Type 2 diabetes

Abstract

Insulin resistance is a condition in which persons with type 2 diabetes make insulin but is unable to use it properly to transfer glucose into cells, resulting in high blood glucose levels. Obesity, particularly visceral fat (fat surrounding the organs) is a major cause of insulin resistance. The homeostasis model evaluation is the gold standard method for determining whether or not a person is insulin resistant. This article tries to investigate the development of the values of some parameters among type 2- diabetic patients versus normal levels of healthy control groups these parameters included FBS, HbAIc (%), FIL, HOMAIR age BMI and lipid profile. The results found that the means values of FBS(mg/dl), HbAIc (%), FIL (miu /L), HOMAIR were (175.96± 39.68, 9.74±1.82 , 18.99±5.98 , 8.136±2.53) respectively versus normal levels of control group (85.44±7.58, 4.92±.500 , 5.79 ± 0.5, 1.22±0.17). While means of age and BMI (kg/m²) of cases were (54.27±13.35, 32.20±2.23) versus the mean for the control group (47.12±10.77, 26.04±1.65) respectively. The levels of total cholesterol (mg/dl), triglycerides (mg/dl), LDL (mg/dl) and VLDL (mg/dl) among type-2 diabetic patients were(238.19±8.27, 183.48±7.66, 117.20±8.59, 36.69±4.28) respectively versus normal concentrations among control groups with mean values (146.03±7.48, 137.54±7.43, 87.55±6.92, 23.6±5.58) respectively, While the mean value of HDL-C was (40.34±9.82) in patients and (52.31± 4.94) in control. In all these parameters there were highly significant differences between case and control (with (p-value= >0.001) and the mean values of patients with type 2 DM were more than control except the values of HDL-C were in patients less than in control. This study found that the results of the tests FBS, HbAIc (%), age BMI and lipid profile in patients with diabetes type 2 in comparison to the control group have a significant correlation with FIL, HOMAIR.

Downloads

Download data is not yet available.

References

Goyal R1 JI. Diabetes Mellitus Type 2. Eur PMC plus. 2020;

Park KY, Hwang HS, Cho KH, Han K, Nam GE, Kim YH, et al. Body weight fluctuation as a risk factor for type 2 diabetes: Results from a nationwide cohort study. J Clin Med. 2019;8(7).

McCance, K.L., & Huether, S. E. (2019). Pathophysiology: The biological basis for disease in adults and children (8th ed.) St. Louis, MO: Mobsy

Zaccardi, F., Webb, D. R., Yates, T., & Davies, M. J. (2016). Psychopathology of Type 1 and Type 2 diabetes mellitus: a 90-year perspective. Postgraduate Medical Journal, 92(1084), 63-69

Habib Yaribeygi, Farin Rashid Farrokhi, Alexandra E. Butler AS. Insulin resistance: Review of the underlying molecular mechanisms. Cell Physiol [Internet]. 2019; Available from: https://doi.org/10.1002/jcp.27603

Antunes LC, Elkfury JL, Jornada MN, Foletto KC, Bertoluci MC. Validation of HOMA-IR in a model of insulin-resistance induced by a high-fat diet in Wistar rats. Arch Endocrinol Metab. 2018;60(2):138–42.

Qinghua Zhanga, Gang, Zhaob NailongY, angcLijuan Z. Chapter Sixteen - Fasting blood glucose levels in patients with different types of diseases. ScienceDirect. 2020;

Shuoning Song, Yuemei Zhang, Xiaolin Qiao, Yanbei Duo, Jiyu Xu, Zhenyao Peng, Jing Zhang, Yan Chen, Xiaorui Nie, Qiujin Sun, Xianchun Yang, Zechun Lu, Shixuan Liu, Tianyi Zhao, Tao Yuan, Yong Fu, Yingyue Dong, Weigang Zhao, Wei Sun AW. HOMA-IR as a risk factor of gestational diabetes mellitus and a novel simple surrogate index in early pregnancy. An Int J Obstet Gynaecol. 2021;

Timpel P, Oswald S, Schwarz PEH, Harst L. Mapping the evidence on the effectiveness of telemedicine interventions in diabetes, dyslipidemia, and hypertension: An umbrella review of systematic reviews and meta-analyses. J Med Internet Res. 2020;22(3).

Babic A, Rosenthal MH, Bamlet WR, Takahashi N, Sugimoto M, Danai L V., et al. Postdiagnosis loss of skeletal muscle, but not adipose tissue, is associated with shorter survival of patients with advanced pancreatic cancer. Cancer Epidemiol Biomarkers Prev. 2019;28(12):2062–9.

Tayek CJ, Cherukuri L, Hamal S, Tayek JA. appraisal. 2019;

Kumar D, Raina S, Sharma SB, Raina SK, Bhardwaj AK. Effectiveness of Randomized Control Trial of Mobile Phone Messages on Control of Fasting Blood Glucose in Patients with Type ‑ 2 Diabetes Mellitus in a Northern State of India. 2019;

Enteshary M, Esfarjani F, Reisi J. Comparison of the Effects of Two Different Intensities of Combined Training on Irisin, Betatrophin, and Insulin Levels in Women with Type 2 Diabetes. Asian J Sports Med. 2019;10(2).

Desjardins EM, Steinberg GR. Emerging Role of AMPK in Brown and Beige Adipose Tissue (BAT): Implications for Obesity, Insulin Resistance, and Type 2 Diabetes. Curr Diab Rep. 2018;18(10).

Liu Y, Ye W, Chen Q, Zhang Y, Kuo CH, Korivi M. Resistance exercise intensity is correlated with attenuation of HbA1c and insulin in patients with type 2 diabetes: A systematic review and meta-analysis. Int J Environ Res Public Health. 2019;16(1).

Chiang JI, Hanlon P, Li TC, Jani BD, Manski-Nankervis JA, Furler J, et al. Multimorbidity, mortality, and HbA1c in type 2 diabetes: A cohort study with UK and Taiwanese cohorts. PLoS Med. 2020;17(5):1–22.

Zehra Esra Önal, Vildan Atasayan, Tamay Gürbüz, Evrim Hepkaya, and Çağatay Nuhoğlu. Association of glycosylated hemoglobin (HbA1c) levels with Insulin resistance in obese children. Afr Health Sci. 2014 Sep; 14(3): 533–538.

Horáková D, Štěpánek L, Janout V, Janoutová J, Pastucha D, Kollárová H, et al. Optimal homeostasis model assessment of insulin resistance (HOMA-IR) cut-offs: A cross-sectional study in the Czech population. Med. 2019;55(5).

Avtanski D, Pavlov VA, Tracey KJ, Poretsky L. Characterization of inflammation and insulin resistance in high‐fat diet‐induced male C57BL/6J mouse model of obesity. Anim Model Exp Med. 2019;2(4):252–8.

Palmer MK, Toth PP. Trends in Lipids, Obesity, Metabolic Syndrome, and Diabetes Mellitus in the United States: An NHANES Analysis (2003-2004 to 2013-2014). Obesity. 2019;27(2):309–14.

Aydin Yoldemir, Ş., Arman, Y., Akarsu, M. et al. The relationship between insulin resistance, obesity, and endotrophin. Int J Diabetes Dev Ctries, 2020;40;191–195.

Made Junior Rina Artha I, Bhargah A, Dharmawan NK, Pande UW, Triyana KA, Mahariski PA, et al. High level of individual lipid profile and lipid ratio as a predictive marker of poor glycemic control in type-2 diabetes mellitus. Vasc Health Risk Manag. 2019;15:149–57.

Shuang Zheng,# Hua Xu,# Huan Zhou,# Xingxing Ren, Tingting Han, Yawen Chen, Huiying Qiu, Peihong Wu, Jun Zheng, Lihua Wang, Wei Liu,* and Yaomin Hu*. Associations of lipid profiles with insulin resistance and β cell function in adults with normal glucose tolerance and different categories of impaired glucose regulation. JournalPLoS One. 2017; 12(2): e0172221.

Brunisholz KD, Joy EA, Hashibe M, Gren LH, Savitz LA, Hamilton S, et al. Incidental Risk of Type 2 Diabetes Mellitus among Patients with Confirmed and Unconfirmed Prediabetes. PLoS One. 2016;11(7):e0157729.